Molecular Weight: 157.10
Molecular Formula: C5H4FN3O2
Canonical SMILES: CCOC(=O)C1=C(NC(=N[C@H]1C2=C(C=C(C=C2)F)Br)C3=NC=CS3)CN4CCO[C@@H](C4)CCC(=O)O
InChI: InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)
InChIKey: ZCGNOVWYSGBHAU-UHFFFAOYSA-N
Boiling Point: 552.6±50.0°C at 760 mmHg
Melting Point: >151°C (dec.)
Purity: ≥97%
Solubility: Soluble in Chloroform (Slightly, Sonicated), DMSO (Slightly), Methanol (Slightly, Sonicated)
Storage: Store at 2-8°C under inert atmosphere
Synonyms: T-705; avigan; 6-Fluoro-3-hydroxypyrazine-2-carboxamide
DescriptionFavipiravir, also known as T-705 or Avigan, is an experimental antiviral drug being developed by Toyama Chemical of Japan with activity against many RNA viruses. Like some other experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. Favipiravir is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses. Activity against enteroviruses and Rift Valley fever virus has also been demonstrated.
More details are to be found on
supplier website
